Colorectal
Ekaterina Baron, MD (she/her/hers)
Surgical Resident
Marshfield Medical Center
Marshfield, Wisconsin, United States
Ekaterina Baron, MD (she/her/hers)
Surgical Resident
Marshfield Medical Center
Marshfield, Wisconsin, United States
Ekaterina Baron, MD (she/her/hers)
Surgical Resident
Marshfield Medical Center
Marshfield, Wisconsin, United States
Chih Ching Wu, MD
Surgical Resident
Marshfield Medical Center, United States
Raquel Abengozar, MD
Surgical Resident
Marshfield Medical Center, United States
Stephanie C. Carr, MD, FACS
Colorectal Surgeon
Marshfield Medical Center, United States
Jessica A. Wernberg, MD, FACS
Surgical Oncologist
Marshfield Medical Center, United States
Rohit Sharma, MD, FACS
Surgical Oncologist
Marshfield Medical Center, United States
The impact of a positive resection margin (RM+) in appendiceal cancer remains unclear. While some small studies suggest RM+ does not correlate with worse survival in low-grade mucinous appendiceal cancer, solid data are lacking. We aimed to assess the RM+ rate in appendix cancer, its risk factors, and survival impact, as colon cancer data cannot be extrapolated due to differences in tumor biology.
Methods:
We conducted a multicenter retrospective cohort study using the National Cancer Database (2004-2019). Stage I-III appendix cancer was included. The association between hypothesized predictors and RM+ after definitive surgery was analyzed with stepwise logistic regression. RM+ impact on overall survival (OS) was assessed with the Kaplan-Meier method and Cox regression. Subgroup analysis was performed among low/high grades and mucinous/non-mucinous pathology.
Results:
Overall, 6,800 patients were identified: 737 (10.8%) with RM+ and 6,063 (89.2%) with RM-. RM+ patients more commonly had signet ring cell pathology (13.3% vs 7.4%, p< 0.01), pT4 disease (68.1% vs 34%, p< 0.01), and positive LNs (33.8% vs 20.6%, p< 0.01) than RM- patients. Appendectomy or ileocecectomy was more common in RM+ (40.3% vs 28.5%) whereas right hemicolectomy was more common in RM- (59.7% vs 71.5%) (p< 0.01). RM+ patients more commonly received pre- (4.2% vs 1.7%, p< 0.01) and postoperative chemotherapy (49.8% vs 37.3%, p< 0.01).
In multivariable analysis, pT3 (ref. pT1-2; OR 4.92; 95%CI 2.38-10.18), pT4 (OR 20.75; 95%CI 10.21-42.17), positive LNs (OR 1.87; 95%CI 1.52-2.31), and high-grade histology (OR 1.32; 95%CI 1.06-1.64) were associated with RM+ while right hemicolectomy (ref. appendectomy or ileocecectomy; OR 0.62; 95%CI 0.50-0.77) was associated with RM-.
Median OS was shorter in patients with RM+ (54 months vs not reached, p< 0.01). Median OS was significantly different between RM+ and RM- in all subgroups: low-grade (p< 0.01) and high-grade mucinous (p< 0.01), low-grade (p< 0.01) and high-grade (p< 0.01) non-mucinous, and signet ring cell carcinoma (p< 0.01) (Figure 1). RM+ was associated with worse OS after adjustment to other factors (HR 1.76; 95%CI 1.47-2.12).
Conclusions:
RM+ correlates with worse survival in all subtypes of stage I-III appendix cancer including low-grade mucinous pathology. Right hemicolectomy and more extensive surgery are associated with RM-. General surgeons and surgical oncologists should prioritize achieving negative margins at definitive surgery for all histological subtypes of appendiceal cancer.